CLAI — CEL AI Share Price
Last trade - 00:00- £0.54m
- -£0.46m
- £0.07m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.33 | ||
| Price to Tang. Book | 0.33 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 10.01 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -128.52% | ||
| Return on Equity | -86.59% | ||
| Operating Margin | -3954.05% | ||
Financial Summary
| Year End 31st Aug | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | n/a | n/a | n/a | 0.03 | 0.07 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CEL AI PLC, formerly Cellular Goods PLC, is a United Kingdom-based wellness company that provides premium products based on lab-made cannabinoids. The Company is engaged in developing and marketing premium skincare and wellness products that help people look, feel and function better. The Company’s primary focus is on three product verticals: Feel Better, Look Better and Function Better. These three verticals encompass Cellular Goods' premium cannabigerol (CBG) skincare and CBD wellness. The Company's products include rejuvenating cannabinoid face serum, SPF 25 rejuvenating day cream, rejuvenating night cream, rejuvenating day mousse, nourishing face oil travel size and various others. The Company’s products are available direct to the consumer through its Website, e-commerce sites, such as Amazon and through physical retail partnerships.
Directors
- Peter Wall NEC (44)
- Anna Chokina CEO
- Simon Walters FID (57)
- Eric Chang COO (42)
- Alexis Abraham OTH (39)
- Alexia Blake OTH
- Sara Hemming OTH
- Ross Connolly NED (37)
- David Gardner NED (43)
- Darcy Taylor NED (52)
- Last Annual
- August 31st, 2023
- Last Interim
- February 29th, 2024
- Incorporated
- August 25th, 2018
- Public Since
- February 26th, 2021
- No. of Employees
- 5
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- London Stock Exchange
- Shares in Issue
- 602,250,000
- Address
- 9th Floor, 16 Great Queen Street, London, WC2B 5DG
- Web
- https://cellular-goods.com/
- Phone
- +44 2070316871
- Auditors
- PKF Littlejohn LLP
Latest News for CLAI
Upcoming Events for CLAI
Similar to CLAI
Asia Strategic Holdings
London Stock Exchange
Brand Architekts
London Stock Exchange
Creightons
London Stock Exchange
DSW Capital
London Stock Exchange
LifeSafe Holdings
London Stock Exchange
FAQ
As of Today at 20:19 UTC, shares in CEL AI are trading at 0.09p. This share price information is delayed by 15 minutes.
Shares in CEL AI last closed at 0.09p and the price had moved by -83.64% over the past 365 days. In terms of relative price strength the CEL AI share price has underperformed the FTSE All Share Index by -84.84% over the past year.
There is no consensus recommendation for this security.
Find out moreCEL AI does not currently pay a dividend.
CEL AI does not currently pay a dividend.
CEL AI does not currently pay a dividend.
To buy shares in CEL AI you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 0.09p, shares in CEL AI had a market capitalisation of £0.54m.
Here are the trading details for CEL AI:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: CLAI
Based on an overall assessment of its quality, value and momentum CEL AI is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CEL AI. Over the past six months, its share price has underperformed the FTSE All Share Index by -74.17%.
As of the last closing price of 0.09p, shares in CEL AI were trading -64.28% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The CEL AI PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 0.09p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
CEL AI's management team is headed by:
- Peter Wall - NEC
- Anna Chokina - CEO
- Simon Walters - FID
- Eric Chang - COO
- Alexis Abraham - OTH
- Alexia Blake - OTH
- Sara Hemming - OTH
- Ross Connolly - NED
- David Gardner - NED
- Darcy Taylor - NED